Dr. Esther Gabor
is Unit Head Microbial Strain Development
Step three in our journey: The production strain does what it is supposed to do, but so far only on a laboratory scale. Now it's time to think big and to scale up the microbial production process to pilot- and industrial scale. Depending on the application this may entail producing the strain as starter culture or probiotic for different purposes e.g. in food or animal feed or as functional biomass for technical processes (e.g. our metal mining / recycling technologies) and/or scaling up a production process for target molecules that the optimized strain was developed to produce.
Using their biology and engineering skills and broad knowledge of process development, BRAIN Biotech’s staff set up upstream and downstream processes in close collaboration with customers. For a process transfer, processes can be scaled and optimized up to 200 liters at the BRAIN Biotech headquarter in Zwingenberg with additional larger scale capacities within the BRAIN Biotech Group – or its network of toll manufacturers, where appropriate.